Page last updated: 2024-10-22

amiodarone and Respiration Disorders

amiodarone has been researched along with Respiration Disorders in 1 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Respiration Disorders: Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.

Research Excerpts

ExcerptRelevanceReference
"Amiodarone pulmonary toxicity is a serious adverse effect that can be fatal."1.31Diagnosis of amiodarone pulmonary toxicity with high-resolution computerized tomographic scan. ( Narula, D; Siniakowicz, RM; Steinberg, JS; Suster, B, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Siniakowicz, RM1
Narula, D1
Suster, B1
Steinberg, JS1

Other Studies

1 other study available for amiodarone and Respiration Disorders

ArticleYear
Diagnosis of amiodarone pulmonary toxicity with high-resolution computerized tomographic scan.
    Journal of cardiovascular electrophysiology, 2001, Volume: 12, Issue:4

    Topics: Acute Disease; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Amiodarone; Case-Control Studies; C

2001